Clarinase Repetabs 120 mg - 5 mg tabl. prol.-rel.

Country: Belgium

Language: English

Source: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Active ingredient:

Pseudoephedrine Sulfate 120 mg; Loratadine 5 mg

Available from:

Bayer SA-NV

ATC code:

R01BA52

INN (International Name):

Loratadine; Pseudoephedrine Sulfate

Dosage:

120 mg - 5 mg

Pharmaceutical form:

Prolonged-release tablet

Composition:

Loratadine 5 mg; Pseudoephedrine Sulfate 120 mg

Administration route:

Oral use

Therapeutic area:

Pseudoephedrine, Combinations; R06AX13 Loratadine

Product summary:

CTI code: 152826-09 - Pack size: 100 - Commercialisation status: NO - Delivery mode: Medical prescription or written request; CTI code: 152826-01 - Pack size: 1 - Commercialisation status: NO - Delivery mode: Free delivery; CTI code: 152826-02 - Pack size: 7 - Commercialisation status: NO - Delivery mode: Medical prescription or written request; CTI code: 152826-03 - Pack size: 10 - Commercialisation status: NO - Delivery mode: Medical prescription or written request; CTI code: 152826-04 - Pack size: 14 - Commercialisation status: YES - FMD code: 04057599000634 - CNK code: 0482778 - Delivery mode: Medical prescription or written request; CTI code: 152826-05 - Pack size: 20 - Commercialisation status: NO - Delivery mode: Medical prescription or written request; CTI code: 152826-06 - Pack size: 28 - Commercialisation status: NO - Delivery mode: Medical prescription or written request; CTI code: 152826-07 - Pack size: 30 - Commercialisation status: NO - Delivery mode: Medical prescription or written request; CTI code: 152826-08 - Pack size: 50 - Commercialisation status: NO - Delivery mode: Medical prescription or written request

Authorization status:

Commercialised: Yes

Authorization date:

1990-10-04